INVESTOR RELATIONS

*15 min delay on quotes.

For all Investor Inquiries: investors@neutrisci.com

CORPORATE PROFILE 

NeutriSci International Inc. (TSXV: NU) develops, markets, and distributes clinically-proven nutraceutical products in Canada. Its products include Neuenergy®, an energy chewable tablet designed to deliver enhanced focus and mental clarity; and BluScience, a nutraceutical product. The company sells its products through a vast distribution network of retail and online channels. NeutriSci International Inc. is headquartered in Calgary, Canada with employees nationwide in Vancouver, Toronto, and Montreal.

NEVER MISS ANOTHER STORY.

Get updates on press releases directly from NeutriSci International! Subscribe to our mailing list today and be the first to know when we publish updates and new press releases.

NeutriSci International complies with Canada’s Anti-Spam Legislation (CASL) and will not spam or sell your information to third party groups.

FOLLOW @NEUTRISCI ON TWITTER

NEUTRISCI IN THE NEWS

Lexaria Bioscience Enters Global Licensing Agreement with Neutrisci International

(NetworkNewsWire, Feb 26, 2018)

From Nutraceuticals to Cannabinoid Pharmaceuticals

(NetworkNewsWire, Jan 26, 2018)

Cannabis MOU Develops Better Drug Delivery System

(Stockhouse, Jan 09, 2018)

NeutriSci, Scientus Pharma in R&D Pact for Medical Cannabinoid

(BioTuesdays, Jan 08, 2018)

NeutriSci Enters Research and Development MOU with Scientus Pharma Inc

(NetworkNewsWire, Jan 08, 2018)

PRESS RELEASES

Contact Us

Send us a message and we'll get back to you as soon as possible.

Not readable? Change text. captcha txt

Start typing and press Enter to search